- Home
- IAF vs JSPR Comparison
IAF vs JSPR Comparison
Compare IAF & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAF
- JSPR
- Stock Information
- Founded
- IAF 1985
- JSPR 2018
- Country
- IAF United States
- JSPR United States
- Employees
- IAF N/A
- JSPR N/A
- Industry
- IAF Finance/Investors Services
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IAF Finance
- JSPR Health Care
- Exchange
- IAF Nasdaq
- JSPR Nasdaq
- Market Cap
- IAF 103.9M
- JSPR 85.8M
- IPO Year
- IAF N/A
- JSPR N/A
- Fundamental
- Price
- IAF $4.45
- JSPR $5.53
- Analyst Decision
- IAF
- JSPR Strong Buy
- Analyst Count
- IAF 0
- JSPR 10
- Target Price
- IAF N/A
- JSPR $62.22
- AVG Volume (30 Days)
- IAF 90.4K
- JSPR 275.1K
- Earning Date
- IAF 01-01-0001
- JSPR 08-12-2025
- Dividend Yield
- IAF 11.44%
- JSPR N/A
- EPS Growth
- IAF N/A
- JSPR N/A
- EPS
- IAF N/A
- JSPR N/A
- Revenue
- IAF N/A
- JSPR N/A
- Revenue This Year
- IAF N/A
- JSPR N/A
- Revenue Next Year
- IAF N/A
- JSPR N/A
- P/E Ratio
- IAF N/A
- JSPR N/A
- Revenue Growth
- IAF N/A
- JSPR N/A
- 52 Week Low
- IAF $3.60
- JSPR $3.13
- 52 Week High
- IAF $4.59
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- IAF 56.39
- JSPR 52.07
- Support Level
- IAF $4.35
- JSPR $4.76
- Resistance Level
- IAF $4.48
- JSPR $5.72
- Average True Range (ATR)
- IAF 0.06
- JSPR 0.41
- MACD
- IAF -0.01
- JSPR -0.06
- Stochastic Oscillator
- IAF 49.44
- JSPR 50.55
About IAF abrdn Australia Equity Fund Inc.
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.